by healthadvances Posted on October 20, 2017April 15, 2020 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More
by healthadvances Posted on February 15, 2017April 15, 2020 Towards a Treatment for the Next Big Liver Disease Read More
by healthadvances Posted on December 2, 2016April 15, 2020 Strategies to Best Capitalize Accelerated Pathways for Innovative Medicines in the 21st Century Read More
by healthadvances Posted on April 11, 2016April 15, 2020 Drug Price Increases-Undue Pricing Power or Supported by Competitive Marketplace? Read More
by healthadvances Posted on November 9, 2015April 15, 2020 Beyond Turing and Valeant- Why is Drug Pricing Such a Hot Issue? Read More
by healthadvances Posted on July 22, 2015April 15, 2020 How Much Longer Before Biopharma Embraces Remote Monitoring in Clinical Trials? Read More
by healthadvances Posted on July 14, 2015April 15, 2020 CAR-T: The Emperor’s New Clothes or The Second Coming? Read More
by healthadvances Posted on July 2, 2015April 15, 2020 Juno Therapeutics and Celgene Ink 10 Year Deal Read More
by healthadvances Posted on June 25, 2015April 15, 2020 Drug Pricing & Reimbursement at the Boston CMO Network Read More
by healthadvances Posted on June 23, 2015April 15, 2020 Health Advances at ADA: Industry Forum Panel “Embracing the Future of Open Data Sharing” Read More
by healthadvances Posted on June 22, 2015April 15, 2020 Pricing Orphan and Specialty Drugs-Insights from the World Orphan Drug Congress & ISPOR Read More
by healthadvances Posted on June 12, 2015April 15, 2020 The Health Evolution Summit Report Published Read More
by healthadvances Posted on May 20, 2015April 15, 2020 Insights from the T1D Exchange Annual Meeting Read More
by healthadvances Posted on May 7, 2015April 15, 2020 Immunotherapy & Combination Therapy Hot Topics at the AACR 2015 Read More
by healthadvances Posted on May 4, 2015April 15, 2020 The Helmsley Trust Awards $8.7M funding for T1D Research Read More
